Dividend aristocrats get plenty of attention, but most of the time the spotlight falls on the big names like Johnson & Johnson (NYSE:JNJ), Coca-Cola (NYSE:KO), and Procter & Gamble (NYSE:PG), among ot
SANTA CLARA, Calif.--(BUSINESS WIRE)-- #Autonomousdriving--PlusAI, a leader in AI software for autonomous trucks, today provided an update on its commercial readiness metrics, demonstrating continued
IRVINE, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. (Nasdaq: MOBX, “Mobix Labs” or the “Company”), a leading provider of advanced connectivity solutions, today announced the pr

Nvidia's Rubin Chips on Track, CEO Huang Says

01:59am, Tuesday, 06'th Jan 2026
Nvidia's highly anticipated Rubin data center processors are in production and customers will soon be able to try out the technology, according to Chief Executive Officer Jensen Huang. Meanwhile, Adva
Novo Nordisk A/S launches oral Wegovy in the U.S. at aggressive introductory pricing, aiming to secure early market share and first-mover advantage. NVO faces imminent semaglutide patent expiry in Chi
NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today
Aerospace & Defense on Track to Become Company's Largest Industrial Business in 2026, Supported by Ongoing Investments and Favorable U.S. Policy Tailwinds Aerospace & Defense on Track to Become Compan
SAN FRANCISCO and BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (“MapLight”) (Nasdaq: MPLT) today announced that the U.S. Food and Drug Administration (FDA) has granted Fas
Shoe Carnival is executing a turnaround by converting stores to the higher-margin Shoe Station brand, targeting middle-income consumers. Short-term headwinds from rebranding are offset by a $50 millio
NAPERVILLE, Ill., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Track Group, Inc. (OTCQB: TRCK), a global leader in offender tracking and monitoring services, today announced financial results for its fiscal year
The U.S. Food and Drug Administration (FDA) is preparing to fast-track reviews of two experimental Merck & Co. Inc. (NYSE: MRK) drugs with potential blockbuster sales.
SAN CARLOS, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration
Shares of Rivian have been rallying after the company posted better-than-expected results. It also held an event highlighting its artificial intelligence (AI) efforts.
Adagene jumps 13.8% after the FDA grants Fast Track Status to muzastotug with pembrolizumab for MSS metastatic colorectal cancer.
Fast Track designation designed to facilitate the development, and expedite the review, of drugs to treat serious conditions and fill an unmet need
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE